CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Ho Maykin Director | Option exercise | +2,816 | 19,848 | ||
| 2026-06-18 | Ho Maykin Director | Option exercise · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Ho Maykin Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2025-06-20 | Ho Maykin Director | Option exercise | +2,120 | 17,032 | ||
| 2025-06-20 | Ho Maykin Director | Option exercise · Restricted stock units | −2,120 | 0 | ||
| 2025-06-18 | Ho Maykin Director | Grant or award · Restricted stock units | +2,816 | 2,816 | ||
| 2025-06-18 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +15,768 | 15,768 | ||
| 2024-06-20 | Ho Maykin Director | Grant or award · Restricted stock units | +2,120 | 2,120 | ||
| 2024-06-20 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +11,774 | 11,774 | ||
| 2024-06-13 | Ho Maykin Director | Option exercise | +3,388 | 14,912 | ||
| 2024-06-13 | Ho Maykin Director | Option exercise · Restricted stock units | −3,388 | 0 | ||
| 2023-06-21 | Ho Maykin Director | Option exercise | +4,975 | 11,524 | ||
| 2023-06-21 | Ho Maykin Director | Option exercise · Restricted stock unit | −4,975 | 0 | ||
| 2023-06-13 | Ho Maykin Director | Grant or award · Restricted stock units | +3,388 | 3,388 | ||
| 2023-06-13 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +18,958 | 18,958 | ||
| 2022-06-21 | Ho Maykin Director | Grant or award · Restricted stock unit | +4,975 | 4,975 | ||
| 2022-06-21 | Ho Maykin Director | Grant or award · Stock options (right to buy) | +29,307 | 29,307 | ||
| 2022-05-20 | Ho Maykin Director | Option exercise | +1,585 | 6,549 | ||
| 2022-05-20 | Ho Maykin Director | Option exercise · Restricted stock unit | −1,585 | 0 |
Page 1 of 2 · 35 trades